Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.

Hyperlipidemia is a risk factor of arteriosclerosis, stroke, and other coronary heart disease, which has been shown to correlate with single nucleotide polymorphisms of genes essential for lipid metabolism, such as lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5). In this study, the effect of...

Full description

Bibliographic Details
Main Authors: Chun-Kai Chang, Xiu-Ru Lin, Yen-Lin Lin, Woei-Horng Fang, Shu-Wha Lin, Sui-Yuan Chang, Jau-Tsuen Kao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5806881?pdf=render
_version_ 1818198852363091968
author Chun-Kai Chang
Xiu-Ru Lin
Yen-Lin Lin
Woei-Horng Fang
Shu-Wha Lin
Sui-Yuan Chang
Jau-Tsuen Kao
author_facet Chun-Kai Chang
Xiu-Ru Lin
Yen-Lin Lin
Woei-Horng Fang
Shu-Wha Lin
Sui-Yuan Chang
Jau-Tsuen Kao
author_sort Chun-Kai Chang
collection DOAJ
description Hyperlipidemia is a risk factor of arteriosclerosis, stroke, and other coronary heart disease, which has been shown to correlate with single nucleotide polymorphisms of genes essential for lipid metabolism, such as lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5). In this study, the effect of magnolol, the main active component extracted from Magnolia officinalis, on LPL activity was investigated. A dose-dependent up-regulation of LPL activity, possibly through increasing LPL mRNA transcription, was observed in mouse 3T3-L1 pre-adipocytes cultured in the presence of magnolol for 6 days. Subsequently, a transgenic knock-in mice carrying APOA5 c.553G>T variant was established and then fed with corn oil with or without magnolol for four days. The baseline plasma triglyceride levels in transgenic knock-in mice were higher than those in wild-type mice, with the highest increase occurred in homozygous transgenic mice (106 mg/dL vs 51 mg/dL, p<0.01). After the induction of hyperglyceridemia along with the administration of magnolol, the plasma triglyceride level in heterozygous transgenic mice was significantly reduced by half. In summary, magnolol could effectively lower the plasma triglyceride levels in APOA5 c.553G>T variant carrier mice and facilitate the triglyceride metabolism in postprandial hypertriglyceridemia.
first_indexed 2024-12-12T02:12:27Z
format Article
id doaj.art-dd1be0e6863e42c59b2914bdc9b85c1f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T02:12:27Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-dd1be0e6863e42c59b2914bdc9b85c1f2022-12-22T00:41:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019274010.1371/journal.pone.0192740Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.Chun-Kai ChangXiu-Ru LinYen-Lin LinWoei-Horng FangShu-Wha LinSui-Yuan ChangJau-Tsuen KaoHyperlipidemia is a risk factor of arteriosclerosis, stroke, and other coronary heart disease, which has been shown to correlate with single nucleotide polymorphisms of genes essential for lipid metabolism, such as lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5). In this study, the effect of magnolol, the main active component extracted from Magnolia officinalis, on LPL activity was investigated. A dose-dependent up-regulation of LPL activity, possibly through increasing LPL mRNA transcription, was observed in mouse 3T3-L1 pre-adipocytes cultured in the presence of magnolol for 6 days. Subsequently, a transgenic knock-in mice carrying APOA5 c.553G>T variant was established and then fed with corn oil with or without magnolol for four days. The baseline plasma triglyceride levels in transgenic knock-in mice were higher than those in wild-type mice, with the highest increase occurred in homozygous transgenic mice (106 mg/dL vs 51 mg/dL, p<0.01). After the induction of hyperglyceridemia along with the administration of magnolol, the plasma triglyceride level in heterozygous transgenic mice was significantly reduced by half. In summary, magnolol could effectively lower the plasma triglyceride levels in APOA5 c.553G>T variant carrier mice and facilitate the triglyceride metabolism in postprandial hypertriglyceridemia.http://europepmc.org/articles/PMC5806881?pdf=render
spellingShingle Chun-Kai Chang
Xiu-Ru Lin
Yen-Lin Lin
Woei-Horng Fang
Shu-Wha Lin
Sui-Yuan Chang
Jau-Tsuen Kao
Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
PLoS ONE
title Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
title_full Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
title_fullStr Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
title_full_unstemmed Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
title_short Magnolol-mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein A5 knock-in mice.
title_sort magnolol mediated regulation of plasma triglyceride through affecting lipoprotein lipase activity in apolipoprotein a5 knock in mice
url http://europepmc.org/articles/PMC5806881?pdf=render
work_keys_str_mv AT chunkaichang magnololmediatedregulationofplasmatriglyceridethroughaffectinglipoproteinlipaseactivityinapolipoproteina5knockinmice
AT xiurulin magnololmediatedregulationofplasmatriglyceridethroughaffectinglipoproteinlipaseactivityinapolipoproteina5knockinmice
AT yenlinlin magnololmediatedregulationofplasmatriglyceridethroughaffectinglipoproteinlipaseactivityinapolipoproteina5knockinmice
AT woeihorngfang magnololmediatedregulationofplasmatriglyceridethroughaffectinglipoproteinlipaseactivityinapolipoproteina5knockinmice
AT shuwhalin magnololmediatedregulationofplasmatriglyceridethroughaffectinglipoproteinlipaseactivityinapolipoproteina5knockinmice
AT suiyuanchang magnololmediatedregulationofplasmatriglyceridethroughaffectinglipoproteinlipaseactivityinapolipoproteina5knockinmice
AT jautsuenkao magnololmediatedregulationofplasmatriglyceridethroughaffectinglipoproteinlipaseactivityinapolipoproteina5knockinmice